PubRank

P Lambin

Author PubWeight™ 103.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Low-dose hypersensitivity: current status and possible mechanisms. Int J Radiat Oncol Biol Phys 2001 2.14
2 Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer. Ann Oncol 2005 1.96
3 Methods for the quantification of DNA double-strand breaks determined from the distribution of DNA fragment sizes measured by pulsed-field gel electrophoresis. Radiat Res 1995 1.61
4 Camurati-Engelmann disease: a late and sporadic case with metaphyseal involvement. Eur Radiol 1999 1.61
5 Reliability of molecular weight determination of proteins by polyacrylamide gradient gel electrophoresis in the presence of sodium dodecyl sulfate. Anal Biochem 1978 1.57
6 Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinoma. Int J Radiat Oncol Biol Phys 1994 1.51
7 Frequency and prognostic importance of thrombocytopenia in symptom-free HIV-infected individuals: a 5-year prospective study. AIDS 1991 1.46
8 Is pulsed dose rate more damaging to spinal cord of rats than continuous low dose rate? Radiother Oncol 1997 1.46
9 Hypoxia as a target for combined modality treatments. Eur J Cancer 2002 1.24
10 Hypersensitivity to very-low single radiation doses: its relationship to the adaptive response and induced radioresistance. Mutat Res 1996 1.19
11 Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo. Br J Cancer 2006 1.19
12 Early versus late chest radiotherapy for limited stage small cell lung cancer. Cochrane Database Syst Rev 2005 1.17
13 Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types. Br J Cancer 2008 1.15
14 Specific targeting of cytosine deaminase to solid tumors by engineered Clostridium acetobutylicum. Cancer Gene Ther 2001 1.12
15 Low dose hyper-radiosensitivity and increased radioresistance in mammalian cells. Int J Radiat Biol 1997 1.11
16 Selective serum IgA deficiency. Frequency among 15,200 French blood donors. Vox Sang 1973 1.10
17 Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study. Ann Oncol 2008 1.08
18 Comparison of Bayesian network and support vector machine models for two-year survival prediction in lung cancer patients treated with radiotherapy. Med Phys 2010 1.06
19 Radio-responsive recA promoter significantly increases TNFalpha production in recombinant clostridia after 2 Gy irradiation. Gene Ther 2001 1.05
20 Improvement of Clostridium tumour targeting vectors evaluated in rat rhabdomyosarcomas. FEMS Immunol Med Microbiol 2001 1.04
21 Frequency of monoclonal gammapathy ('M components') in 13,400 sera from blood donors. Vox Sang 1972 1.04
22 Vascular targeting of solid tumours: a major 'inverse' volume-response relationship following combretastatin A-4 phosphate treatment of rat rhabdomyosarcomas. Eur J Cancer 2000 1.04
23 Purification of the human serum inter-alpha-trypsin inhibitor by zinc chelate and hydrophobic interaction chromatographies. Anal Biochem 1980 1.02
24 Tumor-specific gene delivery using genetically engineered bacteria. Curr Gene Ther 2003 1.00
25 Tumoural perfusion as measured by dynamic computed tomography in head and neck carcinoma. Radiother Oncol 1999 0.99
26 Molecular weight estimation of proteins by electrophoresis in linear polyacrylamide gradient gels in the absence of denaturing agents. Anal Biochem 1979 0.98
27 A new method for determination of molecular weights of proteins by electrophoresis across a sodium dodecyl sulfate (SDS)-polyacrylamide gradient gel. Anal Biochem 1976 0.98
28 Human monoclonal antibody against Rh(D) antigen: partial characterization of the Rh(D) polypeptide from human erythrocytes. Blood 1987 0.97
29 Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients. Ann Oncol 2007 0.96
30 Phased attenuation correction in respiration correlated computed tomography/positron emitted tomography. Med Phys 2006 0.96
31 Changes in the oxygenation of head and neck tumors during carbogen breathing. Radiother Oncol 1993 0.95
32 Monoclonal gammopathies in asymptomatic HIV-seropositive patients. Clin Chem 1987 0.93
33 Impact of fatigue on overall quality of life in lung and breast cancer patients selected for high-dose radiotherapy. Ann Oncol 2007 0.92
34 Stable Escherichia coli-Clostridium acetobutylicum shuttle vector for secretion of murine tumor necrosis factor alpha. Appl Environ Microbiol 1999 0.92
35 Potential role for low dose limited-field radiation therapy (2 x 2 grays) in advanced low-grade non-Hodgkin's lymphomas. Hematol Oncol 1994 0.92
36 Flow cytometric monitoring of allergen induced basophil activation. Cytometry 1995 0.91
37 Oxygenation of head and neck tumors. Cancer 1993 0.90
38 Efficient isolation of total RNA from Clostridium without DNA contamination. J Microbiol Methods 2001 0.90
39 Malignant evolution of asymptomatic monoclonal IgM after seven and fifteen years in two siblings of a patient with Waldenström's macroglobulinemia. Acta Med Scand 1982 0.90
40 Non-invasive 19F MR spectroscopy of 5-fluorocytosine to 5-fluorouracil conversion by recombinant Salmonella in tumours. Br J Cancer 2003 0.90
41 Independent and functional validation of a multi-tumour-type proliferation signature. Br J Cancer 2012 0.90
42 The use of radiation-induced bacterial promoters in anaerobic conditions: a means to control gene expression in clostridium-mediated therapy for cancer. Radiat Res 2001 0.90
43 Decreased DNA-PK activity in human cancer cells exhibiting hypersensitivity to low-dose irradiation. Br J Cancer 2000 0.89
44 Flow cytometric evaluation of human basophils. Cytometry 1993 0.89
45 A global calibration model for a-Si EPIDs used for transit dosimetry. Med Phys 2007 0.88
46 Increasing specificity of anti-tumor therapy: cytotoxic protein delivery by non-pathogenic clostridia under regulation of radio-induced promoters. Anticancer Res 2001 0.87
47 Non-invasive tumour perfusion measurement by dynamic CT: preliminary results. Radiother Oncol 1997 0.87
48 Adverse transfusion reactions associated with a precipitating anti-C4 antibody of anti-Rodgers specificity. Vox Sang 1984 0.87
49 Insertion or deletion of the Cheo box modifies radiation inducibility of Clostridium promoters. Appl Environ Microbiol 2001 0.86
50 Prospective follow-up of monoclonal gammopathies in HIV-infected individuals. Br J Haematol 1993 0.85
51 Systematic survey of monoclonal gammapathies in the sera from blood donors. Transfusion 1979 0.85
52 Purification and partial characterization of a hepatocyte antiproliferative glycopeptide. J Cell Biochem 1989 0.85
53 Isotypic analysis of grass pollen-specific immunoglobulins in human plasma. 1. Specialization of certain classes and subclasses in the immune response. Int Arch Allergy Immunol 1993 0.84
54 In vivo antitumor effect of vascular targeting combined with either ionizing radiation or anti-angiogenesis treatment. Int J Radiat Oncol Biol Phys 2001 0.84
55 The extracellular domain of the human erythropoietin receptor: expression as a fusion protein in Escherichia coli, purification, and biological properties. Prep Biochem Biotechnol 1999 0.84
56 The utility of SPECT in determining the relationship between radiation dose and salivary gland dysfunction after radiotherapy. Nucl Med Commun 2001 0.84
57 Prediction of DVH parameter changes due to setup errors for breast cancer treatment based on 2D portal dosimetry. Med Phys 2009 0.83
58 Follow-up of subjects with isolated and persistent anti-core (anti-p24 or anti-p17) antibodies to HIV. AIDS 1988 0.83
59 Clostridium spores for tumor-specific drug delivery. Anticancer Drugs 2002 0.83
60 Verification of treatment parameter transfer by means of electronic portal dosimetry. Med Phys 2004 0.83
61 Lhermitte sign and myelopathy after irradiation of the cervical spinal cord in radiotherapy treatment of head and neck cancer. Strahlenther Onkol 2011 0.82
62 Serum neopterin and beta 2-microglobulin in anti-HIV positive blood donors. Lancet 1986 0.82
63 Serum neopterin and beta 2-microglobulin concentrations in monoclonal gammopathies. Acta Med Scand 1988 0.82
64 BOLD contrast fMRI of whole rodent tumour during air or carbogen breathing using echo-planar imaging at 1.5 T. Eur Radiol 2001 0.82
65 Follow-up of monoclonal gammopathies in asymptomatic HIV-infected subjects. Clin Chem 1989 0.82
66 Isotypic analysis of grass-pollen-specific immunoglobulins in human plasma. 2. Quantification of the IgE, IgM, IgA class and the IgG subclass antibodies. Int Arch Allergy Immunol 1993 0.82
67 Local production of IgG and IgG subclasses in the aqueous humor of patients with Fuchs heterochromic cyclitis, herpetic uveitis and toxoplasmic chorioretinitis. Int Ophthalmol 1998 0.81
68 Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy? A double-blind randomized trial. Radiother Oncol 1998 0.81
69 Rapid progression to AIDS in dual HIV-1/HTLV-I infection. Lancet 1990 0.81
70 Relocatable fixation systems in intracranial stereotactic radiotherapy. Accuracy of serial CT scans and patient acceptance in a randomized design. Strahlenther Onkol 2011 0.81
71 Selective deficit in antibodies specific for the superantigen binding site of gp120 in HIV infection. FASEB J 1998 0.81
72 Monoclonal IgD. A comparative study of 60 sera with IgD "M" component. Biomedicine 1974 0.81
73 [Studies on human alpha-2 macroglobulin structure and its complexes with proteases, using polyacrylamide gel electrophoresis]. Rev Fr Transfus Immunohematol 1975 0.80
74 Adaptive response and induced resistance. C R Acad Sci III 1999 0.80
75 Sedimentation rate as a predictive marker in HIV infection. AIDS 1988 0.80
76 Preparation and biological properties of monoclonal antibodies against human erythropoietin. Hybridoma 1993 0.80
77 Waldenström's macroglobulinemia in monozygotic twins. Acta Med Scand 1986 0.80
78 Progression to AIDS in the majority of asymptomatic HIV-infected people. AIDS 1989 0.80
79 Selective alterations of the antibody response to HIV-1. Appl Biochem Biotechnol 1998 0.80
80 Radiation-induced oesophagitis in lung cancer patients. Is susceptibility for neutropenia a risk factor? Strahlenther Onkol 2012 0.80
81 IgG monoclonal gammapathy in the sister of a patient with Waldenström's macroglobulinaemia. Biomedicine 1973 0.80
82 Efficacy of gene therapy-delivered cytosine deaminase is determined by enzymatic activity but not expression. Br J Cancer 2007 0.79
83 Clostridium as a tumor-specific delivery system of therapeutic proteins. Cancer Detect Prev 2001 0.79
84 Characterization of the D, c, E and G antigens of the Rh blood group system with human monoclonal antibodies. Mol Immunol 1988 0.79
85 Current preclinical and clinical applications of hypoxia PET imaging using 2-nitroimidazoles. Q J Nucl Med Mol Imaging 2014 0.79
86 Albumin Vanves: a new fast-moving variant of European origin. Hum Hered 1982 0.79
87 Size heterogeneity of human IgA myeloma proteins. Relationships between polymers and "J" chain. Biomedicine 1973 0.78
88 Neopterin and beta 2-microglobulin in serum of HIV-seropositive subjects during a two-year follow-up. Clin Chem 1988 0.78
89 Human albumin variants. Nomenclature of allotypes observed in Europe and quantitative estimation of their relative mobilities. Rev Fr Transfus Immunohematol 1982 0.78
90 Production and properties of monoclonal antibodies against human IgG isotypes. Hybridoma 1996 0.78
91 In vivo antitumour effect of combretastatin A-4 phosphate added to fractionated irradiation. Anticancer Res 2006 0.78
92 Characterization of the blood group Kell (K1) antigen with a human monoclonal antibody. Blood 1989 0.78
93 Distribution of heavy chain classes and light chain types in 757 cases of monoclonal gammapathies. Biomedicine 1975 0.77
94 Blocking antibodies to inhalant allergens and asthma. Allerg Immunol (Paris) 1991 0.77
95 [High molecular-weight polymers in human albumin solutions. Quantitative determination by polyacrylamide gradient electrophoresis]. Rev Fr Transfus Immunohematol 1982 0.77
96 Standardization and mass application of combined live measles-smallpox vaccine in Upper Volta. Am J Epidemiol 1967 0.77
97 Probing the specificity of human myeloma proteins with a random peptide phage library. Scand J Immunol 2003 0.77
98 Inhibition of plasmin by a small molecular weight inhibitor derived from human inter alpha trypsin inhibitor. Thromb Res 1978 0.77
99 Inhibition of human pancreatic elastase II activity on human aortic elastin by human alpha 2-macroglobulin. Experientia 1986 0.77
100 [Monoclonal macroglobulinemia of familial nature present in 3 siblings]. Transfusion (Paris) 1966 0.77
101 Frequency and relevance of IgM intrathecal synthesis in multiple sclerosis. Eur J Neurol 1995 0.77
102 Virological and immunological data of AIDS patients treated by passive immunotherapy (transfusions of plasma rich in HIV-1 antibodies). Vox Sang 1997 0.76
103 Evolution towards AIDS in HIV-infected individuals. Lancet 1988 0.76
104 Increased IgA as a predictor of development of AIDS in HIV-infected subjects. Clin Chem 1988 0.76
105 Quantitative determination of anti-K (KEL1) IgG and IgG subclasses in the serum of severely alloimmunized pregnant women by ELISA. Transfusion 2000 0.76
106 Isolation from human urines of a mucin with blood group SDa activity. Biochem Biophys Res Commun 1982 0.76
107 Tumor oxygenation after 1) carbogen and/or perflubron emulsion administration in tumor xenografts 2) carbogen administration in patients. Artif Cells Blood Substit Immobil Biotechnol 1994 0.76
108 Enzyme immunoassays for detection of malarial antigens in human plasmas by Plasmodium falciparum monoclonal antibodies. Am J Trop Med Hyg 1990 0.75
109 Erythroblastic synartesis: an auto-immune dyserythropoiesis. Blood 1999 0.75
110 Organizational development trajectory of a large academic radiotherapy department set up similarly to a prospective clinical trial: the MAASTRO experience. Br J Radiol 2015 0.75
111 Accelerated radiotherapy with carbogen and nicotinamide (ARCON) in high grade malignant gliomas. Radiother Oncol 1997 0.75
112 Tumor size in cervix cancer and metastases. Radiother Oncol 1999 0.75
113 Curietherapy versus external irradiation combined with curietherapy in stage II squamous cell carcinoma of the mobile tongue. Radiother Oncol 1992 0.75
114 [New findings on an anti-proteinase in human plasma: l'inter-alpha-trypsin inhibitor]. Rev Fr Transfus Immunohematol 1975 0.75
115 The alpha 2 macroglobulin/thrombin interaction in the presence of hydroxylamine. Thromb Res 1983 0.75
116 [A human recombinant erythropoietin produced in human lymphoblastoid cells]. J Pharm Belg 1998 0.75
117 Fibrinogen concentration in asymptomatic HIV-infected individuals. AIDS 1990 0.75
118 [Protease inhibitors]. Rev Fr Transfus Immunohematol 1980 0.75
119 [Tumoral forms of Waldenstrom's macroglobulinemia. Apropos of a case involving 2 localisations, orbital and hepatic]. Sem Hop 1973 0.75
120 Interaction of thrombin with endothelial cells in the presence of fibrinogen and alpha 2-macroglobulin. Haematologia (Budap) 1990 0.75
121 Effect of TNP-470 (AGM-1470) on the growth of rat rhabdomyosarcoma tumors of different sizes. Cancer Invest 2001 0.75
122 Radiotherapy. Eur J Cancer 2001 0.75
123 [Incidence of monoclonal gammopathies in blood donors]. Rev Fr Transfus Immunohematol 1978 0.75
124 [Brachytherapy in cancer of the penis]. Ann Urol (Paris) 1994 0.75
125 [Monoclonal gammapathy of a familial type. Discovery of myeloma in the sister of a patient suffering from Waldenstrom's macroglobulinemia]. Nouv Presse Med 1976 0.75
126 [Release from human alpha 2-macroglobulin of a peptide inhibitor of G1-S transition of hepatocytes in vivo. Role of trypsin, thrombin and various chemical agents]. C R Acad Sci III 1987 0.75
127 [Prediction of the clinical course of AIDS in a cohort of 77 seropositive persons. Importance of p24 antigen in the blood and the level of serum IgA]. Rev Fr Transfus Hemobiol 1990 0.75
128 Association of alpha 2-macroglobulin-thrombin and alpha 2-macroglobulin-plasmin complexes with isolated hepatocytes. Biochim Biophys Acta 1985 0.75
129 [The practical importance of hematologic examinations in the surveillance of radiation exposed persons]. Strahlenschutz Forsch Prax 1964 0.75
130 Efficient production of biologically active human recombinant proteins in human lymphoblastoid cells from integrative and episomal expression vectors. Gene 1994 0.75
131 Isolation of a beta 2-glycoprotein from human serum after precipitation with dextran sulfate and manganese chloride. Biochimie 1983 0.75
132 Experimental foundation of the Gabor-Nelson theory applied to boundaries which are non-insulating. J Theor Biol 1985 0.75
133 Screening of a large number of dyes for the separation of human immunoglobulin G2 from the other immunoglobulin G subclasses immunoglobulin G2 enrichment on immobilized Procion Yellow HE-4R. J Chromatogr A 1997 0.75
134 Clinical and biological features in the 12 months preceding onset of AIDS in HIV-infected subjects. J Acquir Immune Defic Syndr 1989 0.75
135 Quantitation of immunoglobulin classes and subclasses of autoantibodies bound to red cells in patients with and without hemolysis. Transfusion 1993 0.75
136 Chromatography of human immunoglobulin G on immobilized drimarene rubine R/K-5BL. Study of mild, efficient elution procedures. J Chromatogr A 1994 0.75
137 Radiation therapy of cancer of the penis. Indications, advantages, and pitfalls. Urol Clin North Am 1992 0.75
138 [Determination of the molecular weight of proteins by electrophoresis in polyacrylamide gradient in the presence of sodium dodecyl sulfate]. C R Acad Sci Hebd Seances Acad Sci D 1976 0.75
139 The evolution of asymptomatic monoclonal gammopathies. A follow-up of 20 cases over periods of 3-14 years. Acta Med Scand 1979 0.75
140 Types of size heterogeneity of IgA molecules isolated from myeloma and normal human serum. Adv Exp Med Biol 1974 0.75
141 [IgG4 levels in polyvalent immunoglobulins and immunoglobulins prepared by precipitation with caprylic acid]. Rev Fr Transfus Immunohematol 1987 0.75
142 Apparent diameter of carbon nanotubes in scanning tunnelling microscopy measurements. J Phys Condens Matter 2006 0.75
143 Predominant role of the Fab fragment in delaying hyperacute rejection in guinea pig-to-rat xenotransplantation. Transplantation 1998 0.75
144 Heparin and the progressive anti-thrombin activity of alpha 2-macroglobulin. Thromb Res 1982 0.75
145 Idiotypic specificity of a human monoclonal anti-Rhesus(D) antibody. Ann Inst Pasteur Immunol 1987 0.75
146 Electrophoretic and immunologic studies of a hemagglutinin in the hemolymph of the decapod Macropipus puber. J Invertebr Pathol 1975 0.75
147 No evidence of frequent human immunodeficiency virus type 1 infection in seronegative at-risk individuals. Transfusion 1991 0.75
148 [Protons and ions in the treatment of cancer; a systematic review of the literature]. Ned Tijdschr Geneeskd 2006 0.75
149 [ Biological criteria for prediction of the clinical course leading to AIDS]. Rev Fr Transfus Hemobiol 1990 0.75
150 [Frequency of isolated IgA deficits in the normal population. Study of 15200 blood donnors]. Rev Fr Transfus 1973 0.75
151 Chromatographic separation of recombinant human erythropoietin isoforms. J Chromatogr A 1997 0.75
152 Radiosensitivity of human cell lines to small doses. Are there some clinical implications? Radiat Res 1994 0.75
153 [Biological bases of radioresistance of high grade malignant astrocytoma]. Bull Cancer Radiother 1994 0.75
154 Two-stage rotational disordering of a molecular crystal surface: C60. Phys Rev Lett 2001 0.75
155 Molecular weight determination by polyacrylamide gradient gel electrophoresis. Rev Fr Transfus Immunohematol 1984 0.75
156 Long-term treatment of multiple sclerosis with IgG immunotherapy. Pathol Biol (Paris) 1996 0.75
157 [Proteolytic breakdown of human inter-alpha-trypsin inhibitor by plasmin (author's transl)]. Pathol Biol (Paris) 1977 0.75
158 Structural arrangement in the alpha 2-macroglobulin--thrombin complex. FEBS Lett 1983 0.75
159 [Routine detection of monoclonal gammopathy in a black population of 3,758 in Senegal]. Rev Fr Transfus Immunohematol 1977 0.75
160 Evaluation by enzyme-linked immunosorbent assay of IgG anti-D and IgG subclass concentrations in immunoglobulin preparations. Transfusion 1999 0.75
161 [Electrophoretic detection of monoclonal dysglobulinemias in blood donors]. Rev Fr Transfus 1972 0.75
162 [Electrophoretic behavior of human plasminogen on various media]. Rev Fr Transfus 1974 0.75
163 Simultaneous occurrence of clinical manifestations of myeloma and Waldenström's macroglobulinemia with monoclonal IgG Lambda and IgM Kappa in a single patient. Acta Med Scand 1981 0.75
164 Heparin and plasma proteinase inhibitors: influence of heparin on the inhibition of thrombin by alpha 2 macroglobulin. Adv Exp Med Biol 1984 0.75
165 Serological differentiation of two species of Taterillus (Rodentia, Gerbillidae) from Senegal: T. gracilis (Thomas, 1892) and T. pygargus (Cuvier, 1832). Comp Biochem Physiol A Comp Physiol 1974 0.75
166 [Inhibitory effect of human alpha 2-macroglobulin and a peptide released by trypsin, on the G1-S transition of hepatocytes in vivo]. C R Acad Sci III 1985 0.75
167 [Method for evaluating long term complications. A study from a phase III trial comparing two low dose rates in gynecologic brachytherapy]. Bull Cancer 1994 0.75